Pharmaceutical

Amygdala scores $2m NIAAA grant to develop alcohol use disorder therapy

The grant will support the early development of Amygdala’s ALDH2 Inhibitor currently in pre-clinical development.

Aug 2, 2023 - 20:00
Amygdala scores $2m NIAAA grant to develop alcohol use disorder therapy
The grant will support the early development of Amygdala’s ALDH2 Inhibitor currently in pre-clinical development.
Read the original article

Tags:

Previous Article

FDA warns of reduced efficacy for oral birth control pill Tydemy

Next Article

The risks of endotoxins in water systems: Where they arise and how to respond

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

RT-002 by Revance Therapeutics for Upper Limb Muscle Sp...

Jun 11, 2023

STAT+: PhRMA execs paint grim picture of industry under Medicare drug price negotiation

STAT+: PhRMA execs paint grim picture of industry under...

Apr 19, 2023

STAT+: Biotech executive nominated to Biogen board is mother of director’s child, records show

STAT+: Biotech executive nominated to Biogen board is m...

Jun 14, 2023